BC Advantage Funds

BC Advantage Funds was a venture capital firm based in British Columbia, specializing in investments in early-stage life science, technology, and clean technology companies. Founded in 2003, the firm gained recognition for its strong performance, notably receiving the Canadian Venture Capital Association 'Deal of the Year' award in 2006 for achieving a remarkable 23.4X return on its investment in Aspreva Pharmaceuticals. Additionally, its Advantage Life Science Fund I delivered the highest five-year returns of any retail fund in Canada from 2006 to 2008. However, following the financial crisis of 2008-2009, the firm faced significant challenges in growing and financing its portfolio companies. In July 2016, the Board of Directors determined that the best course of action for maximizing shareholder value was to liquidate and dissolve the company. A special meeting of shareholders was held to approve this decision, leading to the distribution of the company’s remaining assets to shareholders.

Frank Holler

CEO and Partner

16 past transactions

Redlen Technologies

Venture Round in 2014
Redlen Technologies Inc. specializes in the manufacturing of cadmium zinc telluride (CZT) semiconductors, which are crucial for a variety of radiation detection and imaging applications, including nuclear cardiology, CT scanning, baggage scanning, and bomb detection. Founded in 1999 and headquartered in Saanichton, Canada, the company has developed a proprietary production process known as the Traveling Heater Method (THM), which enhances the performance, cost-efficiency, and availability of CZT wafers. This innovation positions Redlen as a leader in the medical and security imaging markets, enabling widespread adoption of advanced detection technologies. Additionally, the company provides high-purity cadmium telluride feedstock solutions for the thin-film solar photovoltaic market, further diversifying its product offerings and contributing to the growth of semiconductor materials in renewable energy applications.

Microvisk Technologies

Venture Round in 2010
Microvisk Technologies is a UK-based company founded in 2004, specializing in the development of advanced medical devices. The company's flagship product, CoagMax, is a point-of-care monitor designed for home patient testing of INR blood levels. Utilizing innovative micro electro mechanical sensors, CoagMax allows patients to self-test in a convenient, safe, and less painful manner. The device incorporates a novel sensor chip embedded in a disposable smart strip, ensuring accurate and efficient coagulation monitoring. Through its technology, Microvisk aims to enhance patient autonomy and improve health outcomes in the management of coagulation disorders.

Aquinox Pharmaceuticals

Series B in 2010
Aquinox Pharmaceuticals Inc., based in Vancouver, Canada, is a clinical-stage pharmaceutical company focused on discovering and developing oral drug candidates for the treatment of inflammatory diseases and cancer. Founded in 2004, the company is engaged in the development and commercialization of small molecule therapeutics. Its notable offerings include AQX-MN100, a drug targeting both cancer and inflammatory conditions, alongside a program aimed at SH2-containing inositol 5'-phosphatase inhibition for blood cell recovery. As of July 2020, Aquinox Pharmaceuticals operates as a subsidiary of Taro Pharmaceuticals Inc.

Redlen Technologies

Venture Round in 2010
Redlen Technologies Inc. specializes in the manufacturing of cadmium zinc telluride (CZT) semiconductors, which are crucial for a variety of radiation detection and imaging applications, including nuclear cardiology, CT scanning, baggage scanning, and bomb detection. Founded in 1999 and headquartered in Saanichton, Canada, the company has developed a proprietary production process known as the Traveling Heater Method (THM), which enhances the performance, cost-efficiency, and availability of CZT wafers. This innovation positions Redlen as a leader in the medical and security imaging markets, enabling widespread adoption of advanced detection technologies. Additionally, the company provides high-purity cadmium telluride feedstock solutions for the thin-film solar photovoltaic market, further diversifying its product offerings and contributing to the growth of semiconductor materials in renewable energy applications.

Microvisk Technologies

Venture Round in 2010
Microvisk Technologies is a UK-based company founded in 2004, specializing in the development of advanced medical devices. The company's flagship product, CoagMax, is a point-of-care monitor designed for home patient testing of INR blood levels. Utilizing innovative micro electro mechanical sensors, CoagMax allows patients to self-test in a convenient, safe, and less painful manner. The device incorporates a novel sensor chip embedded in a disposable smart strip, ensuring accurate and efficient coagulation monitoring. Through its technology, Microvisk aims to enhance patient autonomy and improve health outcomes in the management of coagulation disorders.

Zeugma Systems

Series C in 2009
Zeugma Systems is a privately held telecommunications equipment supplier focused on providing open solutions that enhance service deployment for broadband service providers. The company's flagship product, the Zeugma Services Node, is a service delivery router that combines extensive computing power with advanced service and subscriber management capabilities in a fully redundant system. This innovative equipment allows service providers to quickly prototype and launch new revenue-generating services, manage and monitor session flows on a granular level, and enforce quality of service policies. Additionally, Zeugma Systems offers Zeugma OSS for configuration and health management, along with Smart Series Applications that include tools for quality of experience monitoring, enhanced Internet-based video services, improved voice over IP services, and customizable billing frameworks. Overall, Zeugma Systems aims to streamline the delivery of high-value services while reducing the complexity and number of edge devices required in broadband networks.

Inimex Pharmaceuticals

Series B in 2008
Inimex Pharmaceuticals Inc. is a biopharmaceutical company based in Burnaby, Canada, specializing in the development and commercialization of innate defense regulators (IDRs). These innovative agents are designed to selectively modulate the body's innate immune responses without inducing inflammation. The company's lead product, IMX942, aims to enhance survival rates, mitigate tissue damage, and decrease the risk of bacterial infections. Inimex's IDRs are intended for the treatment of various infections and conditions related to tissue injury, including ventilator-associated pneumonia, tracheobronchitis, bacteremia, endocarditis, mucositis, and certain cancers. Founded in 2001, Inimex Pharmaceuticals is focused on advancing its clinical-stage products to improve patient outcomes.

NPS

Venture Round in 2008
NPS was founded in November 2003 in order to exploit polymer technology invented and developed by UK Government research laboratories. Having established an exclusive licence to the technology, NPS has been working to apply it to specific applications across many industries.

Mobidia Technology

Venture Round in 2008
Mobidia Technology Inc., established in 2004 and headquartered in Richmond, Canada, specializes in providing global mobile app and network usage data solutions. The company offers datasets including app data, network data, device data, and plan data, along with methodology, delivery, and dashboard solutions. Mobidia's platforms enable businesses to track competitors, identify trends, optimize data plans, develop over-the-top strategies, and target advertising effectively using real-world usage data worldwide. Notably, Mobidia is also the provider of the popular My Data Manager application for iOS and Android users. As of May 6, 2015, Mobidia operates as a subsidiary of App Annie Limited.

Zeugma Systems

Series B in 2007
Zeugma Systems is a privately held telecommunications equipment supplier focused on providing open solutions that enhance service deployment for broadband service providers. The company's flagship product, the Zeugma Services Node, is a service delivery router that combines extensive computing power with advanced service and subscriber management capabilities in a fully redundant system. This innovative equipment allows service providers to quickly prototype and launch new revenue-generating services, manage and monitor session flows on a granular level, and enforce quality of service policies. Additionally, Zeugma Systems offers Zeugma OSS for configuration and health management, along with Smart Series Applications that include tools for quality of experience monitoring, enhanced Internet-based video services, improved voice over IP services, and customizable billing frameworks. Overall, Zeugma Systems aims to streamline the delivery of high-value services while reducing the complexity and number of edge devices required in broadband networks.

Aquinox Pharmaceuticals

Series A in 2007
Aquinox Pharmaceuticals Inc., based in Vancouver, Canada, is a clinical-stage pharmaceutical company focused on discovering and developing oral drug candidates for the treatment of inflammatory diseases and cancer. Founded in 2004, the company is engaged in the development and commercialization of small molecule therapeutics. Its notable offerings include AQX-MN100, a drug targeting both cancer and inflammatory conditions, alongside a program aimed at SH2-containing inositol 5'-phosphatase inhibition for blood cell recovery. As of July 2020, Aquinox Pharmaceuticals operates as a subsidiary of Taro Pharmaceuticals Inc.

Contigo Systems

Series B in 2007
Contigo Systems Inc. is a Canadian company that specializes in developing and managing a location-based services platform designed for businesses to monitor their vehicles, assets, and personnel through the Internet. The company offers solutions such as RideAlong, a GPS tracking system that supports fleet, asset, and personnel management. Additionally, Contigo provides enterprise-grade lone worker alert solutions aimed at enhancing the safety of mobile workers who operate alone or in high-risk environments, ensuring compliance with relevant legislation. The company distributes its products through a network of strategic partners and value-added resellers, serving enterprise customers and major wireless carriers primarily in the United States and Canada. Founded in 2002 and originally known as Guardian Mobile Monitoring Systems, Contigo is headquartered in Vancouver, British Columbia, with an additional office in Santa Monica, California. As of early 2016, it operates as a subsidiary of Vecima Networks Inc.

Mobidia Technology

Series A in 2007
Mobidia Technology Inc., established in 2004 and headquartered in Richmond, Canada, specializes in providing global mobile app and network usage data solutions. The company offers datasets including app data, network data, device data, and plan data, along with methodology, delivery, and dashboard solutions. Mobidia's platforms enable businesses to track competitors, identify trends, optimize data plans, develop over-the-top strategies, and target advertising effectively using real-world usage data worldwide. Notably, Mobidia is also the provider of the popular My Data Manager application for iOS and Android users. As of May 6, 2015, Mobidia operates as a subsidiary of App Annie Limited.

Metrobridge

Series B in 2005
MetroBridge Networks Corporation is a privately held company specializing in broadband wireless access through advanced technologies. With a robust redundant microwave network, it offers internet connectivity of up to 100 Mbps across its entire coverage area, and speeds reaching 1 Gbps in urban centers. Formed from the merger of two leading local broadband providers, Universco and AirCelerator, MetroBridge aims to serve a diverse clientele, including stand-alone businesses, multi-tenant commercial properties, and temporary locations such as construction sites and film productions. Earlier this year, the company distinguished itself by becoming the first Canadian broadband wireless access provider to gain acceptance into the WiMAX Forum.

Mobidia Technology

Series A in 2005
Mobidia Technology Inc., established in 2004 and headquartered in Richmond, Canada, specializes in providing global mobile app and network usage data solutions. The company offers datasets including app data, network data, device data, and plan data, along with methodology, delivery, and dashboard solutions. Mobidia's platforms enable businesses to track competitors, identify trends, optimize data plans, develop over-the-top strategies, and target advertising effectively using real-world usage data worldwide. Notably, Mobidia is also the provider of the popular My Data Manager application for iOS and Android users. As of May 6, 2015, Mobidia operates as a subsidiary of App Annie Limited.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.